A Phase III, Randomized, Double-Blind, Multicentre Study to Evaluate the Safety and Efficacy of 1592U89 in Patients With AIDS Dementia Complex
This study has been completed.
First Posted: August 31, 2001
Last Update Posted: March 17, 2014
Information provided by:
NIH AIDS Clinical Trials Information Service